Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radny

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Water Research X|June 14, 2019
Comprehensive micropollutant screening using LC-HRMS/MS at three riverbank filtration sites to assess natural attenuation and potential implications for human healthJuliane Hollender, Judith Rothardt, Dirk Radny, et al.
The Science of the Total Environment|August 2, 2017
Characterization of a managed aquifer recharge system using multiple tracersChristian Moeck, Dirk Radny, Andrea Popp, et al.
Dermatology (Basel, Switzerland)|October 2, 2004
Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?P Radny, J Bauer, U M Caroli, et al.
The Lancet. Oncology|July 3, 2004
Malignant blue naevus of the scalpPeter Radny, Diana Berner, Thomas K Eigentler, et al.
RMD Open|May 29, 2021
CT-like images of the sacroiliac joint generated from MRI using susceptibility-weighted imaging (SWI) in patients with axial spondyloarthritisDominik Deppe, Kay-Geert Hermann, Fabian Proft, et al.
Scientific Reports|January 11, 2017
Nitrogen loss by anaerobic ammonium oxidation in unconfined aquifer soilsShanyun Wang, Dirk Radny, Shuangbing Huang, et al.
The Science of the Total Environment|November 8, 2017
Spatiotemporal scales of river-groundwater interaction - The role of local interaction processes and regional groundwater regimesJannis Epting, Peter Huggenberger, Dirk Radny, et al.
Journal of the American Academy of Dermatology|July 6, 2007
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinomaThomas K Eigentler, Anne Kamin, Benjamin M Weide, et al.
Cancer|June 22, 2010
High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanomaBenjamin Weide, Evelyna Derhovanessian, Annette Pflugfelder, et al.
British Journal of Cancer|October 30, 2003
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastasesP Radny, U M Caroli, J Bauer, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Water Research X|June 14, 2019
Comprehensive micropollutant screening using LC-HRMS/MS at three riverbank filtration sites to assess natural attenuation and potential implications for human healthJuliane Hollender, Judith Rothardt, Dirk Radny, et al.
The Science of the Total Environment|August 2, 2017
Characterization of a managed aquifer recharge system using multiple tracersChristian Moeck, Dirk Radny, Andrea Popp, et al.
Dermatology (Basel, Switzerland)|October 2, 2004
Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?P Radny, J Bauer, U M Caroli, et al.
The Lancet. Oncology|July 3, 2004
Malignant blue naevus of the scalpPeter Radny, Diana Berner, Thomas K Eigentler, et al.
RMD Open|May 29, 2021
CT-like images of the sacroiliac joint generated from MRI using susceptibility-weighted imaging (SWI) in patients with axial spondyloarthritisDominik Deppe, Kay-Geert Hermann, Fabian Proft, et al.
Scientific Reports|January 11, 2017
Nitrogen loss by anaerobic ammonium oxidation in unconfined aquifer soilsShanyun Wang, Dirk Radny, Shuangbing Huang, et al.
The Science of the Total Environment|November 8, 2017
Spatiotemporal scales of river-groundwater interaction - The role of local interaction processes and regional groundwater regimesJannis Epting, Peter Huggenberger, Dirk Radny, et al.
Journal of the American Academy of Dermatology|July 6, 2007
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinomaThomas K Eigentler, Anne Kamin, Benjamin M Weide, et al.
Cancer|June 22, 2010
High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanomaBenjamin Weide, Evelyna Derhovanessian, Annette Pflugfelder, et al.
British Journal of Cancer|October 30, 2003
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastasesP Radny, U M Caroli, J Bauer, et al.
Pageof 7